View Author
Knight, J.D.
(David Knight)
stroke patient infarction study survival analysis cost-effectiveness gusto treatment hospital streptokinase resource group ratio hospitalization cost-effectiveness ratio baseline follow-up percent t-pa group fi rst year thrombolytic life expectancy value table hemorrhagic baseline hospitalization stroke patients gusto study increase resource use cohort therapy 0.0001 england journal stroke type catheterization mortality stroke survivors no-stroke procedure no-stroke cohort ami patients expectancy difference effect 1- year costs physician gusto i patients thrombolytic therapy 100 patients medicine university disease cost-effectiveness ratios health stroke cohort hemorrhagic stroke patients nonhemorrhagic baseline hospitalization cost survivor tissue plasminogen activator medicine downloaded discharge t-pa treatment trial erasmus university hemorrhagic strokes curve treatment groups 30- day mortality journal england nonhemorrhagic stroke patients topol ej cost differences heart determinant length analyses
2 Most Recent Publications
|
Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study
(Article)
Tung, C.Y. White, H.D. Knight, J.D. Weaver, W.D. Mahaffey, K.W. Clapp-Channing, N. Mark, D.B. Simoons, M.L. Califf, R.M. Gore, J.M. Granger, C.B. Sloan, M.A. Topol, E.J. |
1999-01-01
|
|
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction
(Article)
Mark, D.B. Hlatky, M.A. Harrell, F.E. Simes, R.J. Topol, E.J. Armstrong, P.W. Barbash, G.I. Califf, R.M. Naylor, C.D. Lee, K.L. White, H.D. Simoons, M.L. Nelson, C.L. Clapp-Channing, N. Knight, J.D. |
1995-01-01
|